Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Exclzyme Pet
- Development stage
- Unknown
- Lead developer
- Specialty Enzymes & Probiotics
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Recombinant Proteins and Enzymes
- Administration
- Oral
01
Overview
Exclzyme Pet is a veterinary nutraceutical and systemic enzyme blend developed by Specialty Enzymes & Probiotics. It is formulated to support joint health, tissue repair, and muscle recovery in companion animals, particularly dogs. The supplement is composed of multiple active enzymatic ingredients, including amylase, bromelain, lipase, papain, Peptizyme SP EN (serratiopeptidase), and proteases, combined with herbal extracts such as amla and rutin. Rather than targeting cartilage substrates like traditional joint supplements, Exclzyme Pet acts on the body's normal inflammatory pathways to resolve inflammation. In a randomized, double-blind, placebo-controlled clinical trial in dogs with osteoarthritis, supplementation with Exclzyme Pet led to significant reductions in pain, lameness, and serum C-reactive protein (CRP) levels, with 92% of treated dogs showing measurable improvement.
- Brand names
- Exclzyme Pet
Beyond the preview
Go deeper on Exclzyme Pet.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Exclzyme Pet.